Clinical trial
Open-label Extension Trial for Pre- and Postmenopausal Women With HSDD
NCT01103362 is registered in ClinicalTrials.gov with Sprout Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label Extension Trial for Pre- and Postmenopausal Women With HSDD
- Lead sponsor
- Sprout Pharmaceuticals, Inc
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 30, 2010
- Completion date
- January 31, 2011
- Enrollment
- 596 (actual)
- Sites
- 95
Conditions
As the registry lists them; a condition with its own page is linked.